Oil prices mixed ahead of U.S. crude stock data
By Collin Eaton HOUSTON (Reuters) - Oil prices were mixed on Tuesday ahead of data expected to show U.S. crude stocks declining, outweighing investors' concerns that U.S.-China trade tensions could dampen fuel demand
By Collin Eaton
HOUSTON (Reuters) - Oil prices were mixed on Tuesday ahead of data expected to show U.S. crude stocks declining, outweighing investors' concerns that U.S.-China trade tensions could dampen fuel demand.
Benchmark Brent crude futures settled up 19 cents, or 0.3%, at $65.05 a barrel.
U.S. crude futures fell 7 cents, or about 0.1%, at $57.83 a barrel.
Investors shrugged off U.S. President Donald Trump's comments on Tuesday that the United States would obliterate parts of Iran if it attacked "anything American."
Oil-market jitters over the escalating tension between the United States and Iran have eased after Trump targeted Supreme Leader Ayatollah Ali Khamenei and other top Iranian officials with sanctions on Monday, after calling off a retaliatory air strike, analysts said.
Sending a bullish signal, a preliminary Reuters poll showed on Monday that U.S. crude oil inventories likely fell for a second consecutive week last week.
The numbers came ahead of crude stock data from the American Petroleum Institute (API), an industry group, at 4:30 p.m. EDT (2030 GMT) on Tuesday, and the Energy Information Administration (EIA), an agency of the U.S. Department of Energy, due on Wednesday.
But concerns over U.S.-China trade tensions and global growth still were pressuring prices, analysts said.
"You're going to see oil have trouble picking a direction over the next couple days," said Josh Graves, senior market strategist at RJO Futures in Chicago. "There's a tug-of-war between bullish and bearish factors."
Weighing on prices, hopes for progress in the trade war between China and the United States during this week's G20 meeting were dampened by a senior U.S. official saying Trump was "comfortable with any outcome" from the talks.
"The U.S.-China meeting on the side of G20 could signal further rapprochement on trade, but the market needs something it can sink it's teeth into," said Gene McGillian, vice president of market research at Tradition Energy in Stamford, Connecticut.
"We've been going back and forth on U.S.-China trade disputes for over a year now," McGillian added.
Demand concerns were briefly overcome last week when Brent climbed 5% and U.S. crude surged almost 10%, its strongest week since 2016, after Iran shot down a U.S. drone, adding to tensions stoked by previous attacks on oil tankers in the area.
Washington has blamed the tanker attacks on Iran, which denies any role.
The Organization of the Petroleum Exporting Countries and its allies including Russia appear likely to extend a deal on curbing output when they meet on July 1-2.
Russian Energy Minister Alexander Novak said international cooperation on crude production had helped stabilize oil markets and was more important than ever. He also voiced concerns about demand.
The chief executive of Saudi Aramco, the state oil firm of OPEC's de facto leader, said its spare capacity of 12 million barrels per day (bpd) was sufficient and that it would meet its customers' needs.
U.S. sanctions on Iran and Venezuela have cut oil exports from the two OPEC members, but U.S. production has been rising.
(Reporting by Collin Eaton; Additional reporting by Shadia Nasralla in London, Aaron Sheldrick in TOKYO; Editing by Lisa Shumaker)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Rami Amichay HAIFA, Israel (Reuters) - The ship-to-shore crane paused above the cargo ship just arrived from Dubai, then set its load down on the pier in Israel.
By Noor Zainab Hussain, Carolyn Cohn and Ludwig Burger LONDON/FRANKFURT (Reuters) - The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour. Yet, while more than 40 experimental COVID-19 vaccines are being tested on humans, the insurance companies with decades of experience in assessing the risks of clinical trials don't see anything to be unduly concerned about.
By Huw Jones LONDON (Reuters) - The European Union's securities watchdog said it expects to make a statement soon on where shares listed in the bloc must be traded after Britain's full departure from the European Union in December.